Connect with us

Hi, what are you looking for?

Saturday, Dec 2, 2023
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

AI and Autonomy

Infosys and NVIDIA expand partnership to build generative AI for businesses

The expanded partnership offers a scalable, cost-effective platform using NVIDIA technology to augment Infosys’ Responsible AI Toolkit

Infosys and NVIDIA build generative AI for businesses
NVIDIA CEO Jensen Heuang (left) and Infosys Chairman Nandan Nilekani. Image via Infosys.

Global IT company Infosys Ltd. (NSE: INFY) (BSE: INFY) (NYSE: INFY) and NVIDIA Corp. (NASDAQ: NVDA) expanded its existing collaboration to include producing a generative AI platform to help enterprises drive productivity.

Infosys said on Monday that the collaboration will involve using computer vision technology to tackle retail industry challenges, improve shopping experiences, monitor inventory in real-time and ensure compliance with health and safety regulations. These advancements also extend to logistics, manufacturing and utilities.

Infosys Generative AI Labs and the NVIDIA NeMo framework for training conversational AI models will also come together to facilitate the efficient deployment of large language models tailored for diverse enterprise applications.

This expanded partnership offers a scalable and cost-effective platform while incorporating NVIDIA technology to augment Infosys’ Responsible AI Toolkit, handling potential risks like intellectual property infringement, bias, toxicity, hallucinations and security threats.

Additionally, Infosys utilizes Infosys Cortex alongside NVIDIA Riva speech and translation AI to develop AI-driven contact center platforms. These solutions include language neutralization for seamless multilingual support and real-time customer intent and sentiment analysis tools to elevate customer satisfaction and promote brand loyalty.

Read more: Microsoft partners combine to form AI-oriented consultancy firm Lantern

Read more: Artificial intelligence can be used to detect polycystic ovary syndrome: NIH study

Infosys intends to establish a NVIDIA Centre of Excellence

The expanded partnership will introduce the NVIDIA AI Enterprise ecosystem into Infosys Topaz, which is Infosys’ comprehensive suite of AI-centric services and platforms designed to enhance business outcomes by leveraging generative AI technologies. This integration will enable Infosys to develop customer-oriented platforms using generative AI.

Infosys also intends to establish a NVIDIA Centre of Excellence, dedicated to the training and certification of 50,000 of its staff in NVIDIA AI technology. This initiative aims to equip its extensive workforce with expertise in generative AI, enabling them to deliver valuable AI solutions to customers across various industries within the Infosys network.

“Infosys is transforming into an AI-first company to better provide AI-based services to our clients worldwide. Our clients are also looking at complex AI use cases that can drive significant business value across their entire value chain,” said Nandan Nilekani, co-founder and chairman of Infosys.

Infosys leverages the comprehensive NVIDIA generative AI platform, encompassing both hardware and enterprise-grade software, to drive innovation throughout its business operations. The company also assists its clients in developing generative AI applications for various aspects such as business operations, sales and marketing.

Shares of Infosys rose 1 per cent to $17.97 on Wednesday on the New York Stock Exchange.

Shares of NVIDIA declined 0.9 per cent to $431.27 on Wednesday on the NASDAQ exchange.


Follow Mugglehead on X

Like Mugglehead on Facebook

Follow Joseph Morton on X

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Hive is going to use this facility to boost bitcoin production in preparation for the halving


The firm aims to discover untapped critical metal deposits in a more cost-effective and time-efficient manner

AI and Autonomy

The system accurately identifies more than 110 complex or rare diseases often missed by conventional methods


An estimated 200,000 scam tokens were created between September 2020 and December 2022